Humanigen Inc (HGENQ)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 17, 09:30
Humanigen Cash from Operations (TTM): -64.32M for March 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2023 | -64.32M |
December 31, 2022 | -76.70M |
September 30, 2022 | -94.39M |
June 30, 2022 | -125.08M |
March 31, 2022 | -167.66M |
December 31, 2021 | -184.04M |
September 30, 2021 | -175.48M |
June 30, 2021 | -151.02M |
March 31, 2021 | -105.07M |
December 31, 2020 | -69.85M |
September 30, 2020 | -46.71M |
June 30, 2020 | -24.34M |
March 31, 2020 | -3.924M |
December 31, 2019 | -4.001M |
September 30, 2019 | -4.676M |
June 30, 2019 | -4.751M |
March 31, 2019 | -5.065M |
December 31, 2018 | -6.209M |
September 30, 2018 | -6.923M |
June 30, 2018 | -9.677M |
March 31, 2018 | -11.71M |
Date | Value |
---|---|
December 31, 2017 | -14.25M |
September 30, 2017 | -15.32M |
June 30, 2017 | -20.30M |
March 31, 2017 | -23.33M |
December 31, 2016 | -20.96M |
September 30, 2016 | -25.94M |
June 30, 2016 | -23.17M |
March 31, 2016 | -22.04M |
December 31, 2015 | -29.06M |
September 30, 2015 | -27.93M |
June 30, 2015 | -30.11M |
March 31, 2015 | -33.66M |
December 31, 2014 | -35.94M |
September 30, 2014 | -39.17M |
June 30, 2014 | -39.09M |
March 31, 2014 | -42.31M |
December 31, 2013 | -38.82M |
September 30, 2013 | -37.28M |
June 30, 2013 | -35.57M |
March 31, 2013 | -28.26M |
December 31, 2012 | -23.91M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-184.04M
Minimum
Dec 2021
-3.924M
Maximum
Mar 2020
-81.38M
Average
-73.28M
Median
Cash from Operations (TTM) Benchmarks
Cannabis Global Inc | -0.9771M |
Item 9 Labs Corp | -1.120M |
Cantabio Pharmaceuticals Inc | -0.7984M |
Affymax Inc | -- |
Statera BioPharma Inc | -12.09M |